• Aucun résultat trouvé

BIOVITIS. Expert en microorganismes. Expert en biotechnologie et écologie microbienne

N/A
N/A
Protected

Academic year: 2022

Partager "BIOVITIS. Expert en microorganismes. Expert en biotechnologie et écologie microbienne"

Copied!
6
0
0

Texte intégral

(1)

Expert en biotechnologie et écologie microbienne

BIOVITIS

Expert en

microorganismes

www.laboratoires-biovitis.fr

(2)

GREENTECH

AN UNLIMITED RESOURCE

GREENTECH gathers its resources from every continent in order to exploit the natural adaptive systems of regional species.

GREENTECH has uncovered over 300,000 bioactive molecules across the world’s latitudes and longitudes, developed a hundred active ingredients and over 3,000 extracts.

CUTTING EDGE RESEARCH

Researchers (one third of our staff) have for over 20 years shared their scientific knowledge across all disciplines (plant biology, botanical science, phytochemistry, microbiology, biochemistry, chemistry, algology, nutrition, cosmetics, etc.).

The laboratory possesses its own data bank of over 30,000 botanicals and 300,000 biological molecules.

High-tech processes used by the pharmaceutics industry transform natural ingredients into actives: ethnobotany, bio-informatics with molecular modelling, transcriptomic analysis (complete genome), fermentation, a patented cryoextraction system that preserves the plants’ active essence...

Mastery of high technologies witnessed by numerous quality accreditations and awards.

Every year, over 15% of turnover is reinvested in R&D.

MICROORGANISMS : AN INEXHAUSTIBLE SOURCE OF DIVERSITY TO MEET THE TOMORROW’S CHALLENGES

GREENSEA values the immense potential of marine and freshwater plants to create, by biotechnological means, totally innovative natural cosmetic active ingredients and extracts.

GREENSEA extracts, purifies, characterizes and transforms active molecules derived from algae and marine plants into highly effective ingredients; proven performance by transcriptomic predictive assays, in vitro cell assays, and in vivo volunteer assays.

Located in Mèze along the Thau Lagoon and the Mediterranean sea, GREENSEA has a rare collection of species, full of beneficial molecules for the skin thanks to an affinity with no equivalence.

A CUSTOMISED SERVICE, WITH EXCLUSIVE OR PERSONALISED ACTIVE INGREDIENTS

GREENTECH develops specific, customised actives for the most demanding brands in the market either exclusively or using existing active ingredients that are adapted to their demands.

Reactivity and Flexibility are the master words in the company.

The GREENTECH’s factory produces in volumes of between 50 kg to 200 t.

A GROUP THAT IS THRIVING

Production site and international presence in constant development : more than 10 000 m2, including 2000 m2 of laboratories equipped with the most sophisticated active ingredients’extraction analysis, stabilisation.

A HIGHLY COMMITTED GROUP, BUILT ON SUSTAINABLE DEVELOPMENT AND FAIR TRADE

Confident that ethic is a source of progress, GREENTECH was also a pioneer in being the first to adopt sustainable practices and fair trade. It has forged long term partnerships based on equal and mutual benefits: Madagascar, Peru, Burkina Faso…

Fully committed to the preservation of rare or threatened species, Greentech collaborates with local communities in over 20 countries around the world from the North and South poles to the Equator.

AN INFINITE SOURCE OF INNOVATIVE ASSETS Harvested from the oceans and seas of the earth and in sometimes extreme environments, macroalgae and marine plants selected by GREENSEA present original cosmetic activities, as well as microalgae produced under controlled conditions. In addition to the extreme diversity of cultivated species, the innovative technique of metabolic orientation developed by GREENSEA makes it possible to create new assets that meet the different needs of the skin and hair.

BLUE BIOTECHNOLOGIES, A PRIVILEGED PATH TO SUSTAINABLE DEVELOPMENT

This unlimited biodiversity makes it possible to develop totally natural and high-tech assets, sources of beauty, with a sustainable development philosophy that is at the heart of GREENSEA and the GREENTECH GROUP.

ONE OF THE EUROPEAN LEADERS

The activity of GREENSEA is totally integrated, from the culture tube to the commercial ingredient. Its large collection of exotic and extremophilic microalgae and cyanobacteria, its expertise in physiological stress for oriented microalgae cultures, its industrial biological cultures in a controlled environment, as well as its 100m³ production capacity on 3 types of closed systems, its quality assurance and the reliability of its traceability make GREENSEA the reference for microalgae in France and one of the European leaders. A pioneer in botanical biotechnology at its creation in 1992, GREENTECH develops high technology extracts and active

ingredients derived from the internal mechanisms of plants, algae, micro-algae and microorganisms from around the world for cosmetics, pharmaceutics and nutraceutics.

A Group of companies dedicated to each biological universe:

BIOVITIS has more than 25 years experience in the production of microorganisms and transformation into innovative ingredients for several markets as Agronomy, Environment, Cosmetic, Pharmacy and Agroindus- try. BIOVITIS has a collection of more than 500 microbial strains in its catalog (bacteria, yeasts and fungi)

Active ingredients and extracts derived from micro-algae, algae and halophyte plants for nutraceutics, dietetics, cosmetics, immunodiagnostics and aquaculture.

MARINE Active ingredients and extracts

derived from plants and biotechnologies for nutraceutics,

pharmaceutics and cosmetics.

BOTANICAL

Biovitis

Microbial biotechnology for nutritional, agronomic, pharmaceutical, dermocosmetic

and environmental purposes.

MICROBIAL

Active ingredients derived from Brazilian biodiversity for the cosmetics, pharmaceutics and

nutraceutics markets.

BRAZILIAN BIODIVERSITY

A PIONEERING GROUP, BIOTECHNOLOGY EXPERT FROM ALL NATURAL ENVIRONMENTS

BIOVITIS GREENTECH

AN UNLIMITED RESOURCE

GREENTECH gathers its resources from every continent in order to exploit the natural adaptive systems of regional species.

GREENTECH has uncovered over 300,000 bioactive molecules across the world’s latitudes and longitudes, developed a hundred active ingredients and over 3,000 extracts.

CUTTING EDGE RESEARCH

Researchers (one third of our staff) have for over 20 years shared their scientific knowledge across all disciplines (plant biology, botanical science, phytochemistry, microbiology, biochemistry, chemistry, algology, nutrition, cosmetics, etc.).

The laboratory possesses its own data bank of over 30,000 botanicals and 300,000 biological molecules.

High-tech processes used by the pharmaceutics industry transform natural ingredients into actives: ethnobotany, bio-informatics with molecular modelling, transcriptomic analysis (complete genome), fermentation, a patented cryoextraction system that preserves the plants’ active essence...

Mastery of high technologies witnessed by numerous quality accreditations and awards.

Every year, over 15% of turnover is reinvested in R&D.

MICROORGANISMS : AN INEXHAUSTIBLE SOURCE OF DIVERSITY TO MEET THE TOMORROW’S CHALLENGES

GREENSEA values the immense potential of marine and freshwater plants to create, by biotechnological means, totally innovative natural cosmetic active ingredients and extracts.

GREENSEA extracts, purifies, characterizes and transforms active molecules derived from algae and marine plants into highly effective ingredients; proven performance by transcriptomic predictive assays, in vitro cell assays, and in vivo volunteer assays.

Located in Mèze along the Thau Lagoon and the Mediterranean sea, GREENSEA has a rare collection of species, full of beneficial molecules for the skin thanks to an affinity with no equivalence.

A CUSTOMISED SERVICE, WITH EXCLUSIVE OR PERSONALISED ACTIVE INGREDIENTS

GREENTECH develops specific, customised actives for the most demanding brands in the market either exclusively or using existing active ingredients that are adapted to their demands.

Reactivity and Flexibility are the master words in the company.

The GREENTECH’s factory produces in volumes of between 50 kg to 200 t.

A GROUP THAT IS THRIVING

Production site and international presence in constant development : more than 10 000 m2, including 2000 m2 of laboratories equipped with the most sophisticated active ingredients’extraction analysis, stabilisation.

A HIGHLY COMMITTED GROUP, BUILT ON SUSTAINABLE DEVELOPMENT AND FAIR TRADE

Confident that ethic is a source of progress, GREENTECH was also a pioneer in being the first to adopt sustainable practices and fair trade. It has forged long term partnerships based on equal and mutual benefits: Madagascar, Peru, Burkina Faso…

Fully committed to the preservation of rare or threatened species, Greentech collaborates with local communities in over 20 countries around the world from the North and South poles to the Equator.

AN INFINITE SOURCE OF INNOVATIVE ASSETS Harvested from the oceans and seas of the earth and in sometimes extreme environments, macroalgae and marine plants selected by GREENSEA present original cosmetic activities, as well as microalgae produced under controlled conditions. In addition to the extreme diversity of cultivated species, the innovative technique of metabolic orientation developed by GREENSEA makes it possible to create new assets that meet the different needs of the skin and hair.

BLUE BIOTECHNOLOGIES, A PRIVILEGED PATH TO SUSTAINABLE DEVELOPMENT

This unlimited biodiversity makes it possible to develop totally natural and high-tech assets, sources of beauty, with a sustainable development philosophy that is at the heart of GREENSEA and the GREENTECH GROUP.

ONE OF THE EUROPEAN LEADERS

The activity of GREENSEA is totally integrated, from the culture tube to the commercial ingredient. Its large collection of exotic and extremophilic microalgae and cyanobacteria, its expertise in physiological stress for oriented microalgae cultures, its industrial biological cultures in a controlled environment, as well as its 100m³ production capacity on 3 types of closed systems, its quality assurance and the reliability of its traceability make GREENSEA the reference for microalgae in France and one of the European leaders. A pioneer in botanical biotechnology at its creation in 1992, GREENTECH develops high technology extracts and active

ingredients derived from the internal mechanisms of plants, algae, micro-algae and microorganisms from around the world for cosmetics, pharmaceutics and nutraceutics.

A Group of companies dedicated to each biological universe:

BIOVITIS has more than 25 years experience in the production of microorganisms and transformation into innovative ingredients for several markets as Agronomy, Environment, Cosmetic, Pharmacy and Agroindus- try. BIOVITIS has a collection of more than 500 microbial strains in its catalog (bacteria, yeasts and fungi)

Active ingredients and extracts derived from micro-algae, algae and halophyte plants for nutraceutics, dietetics, cosmetics, immunodiagnostics and aquaculture.

MARINE Active ingredients and extracts

derived from plants and biotechnologies for nutraceutics,

pharmaceutics and cosmetics.

BOTANICAL

Biovitis

Microbial biotechnology for nutritional, agronomic, pharmaceutical, dermocosmetic

and environmental purposes.

MICROBIAL

Active ingredients derived from Brazilian biodiversity for the cosmetics, pharmaceutics and

nutraceutics markets.

BRAZILIAN BIODIVERSITY

A PIONEERING GROUP, BIOTECHNOLOGY EXPERT FROM ALL NATURAL ENVIRONMENTS

BIOVITIS

UN GROUPE PIONNIER, EXPERT EN BIOTECHNOLOGIES DE TOUS MILIEUX

Pionnier de la biotechnologie végétale à sa création en 1992, GREENTECH développe et produit pour la cosmétique, la pharmacie et la nutraceutique des extraits et actifs de haute technologie, issus des mécanismes profonds des plantes, algues, microalgues et microorganismes puisés dans le monde entier.

Une société est dédiée à chaque univers :

GREENTECH

AN UNLIMITED RESOURCE

GREENTECH gathers its resources from every continent in order to exploit the natural adaptive systems of regional species.

GREENTECH has uncovered over 300,000 bioactive molecules across the world’s latitudes and longitudes, developed a hundred active ingredients and over 3,000 extracts.

CUTTING EDGE RESEARCH

Researchers (one third of our staff) have for over 20 years shared their scientific knowledge across all disciplines (plant biology, botanical science, phytochemistry, microbiology, biochemistry, chemistry, algology, nutrition, cosmetics, etc.).

The laboratory possesses its own data bank of over 30,000 botanicals and 300,000 biological molecules.

High-tech processes used by the pharmaceutics industry transform natural ingredients into actives: ethnobotany, bio-informatics with molecular modelling, transcriptomic analysis (complete genome), fermentation, a patented cryoextraction system that preserves the plants’ active essence...

Mastery of high technologies witnessed by numerous quality accreditations and awards.

Every year, over 15% of turnover is reinvested in R&D.

MICROORGANISMS : AN INEXHAUSTIBLE SOURCE OF DIVERSITY TO MEET THE TOMORROW’S CHALLENGES

GREENSEA values the immense potential of marine and freshwater plants to create, by biotechnological means, totally innovative natural cosmetic active ingredients and extracts.

GREENSEA extracts, purifies, characterizes and transforms active molecules derived from algae and marine plants into highly effective ingredients; proven performance by transcriptomic predictive assays, in vitro cell assays, and in vivo volunteer assays.

Located in Mèze along the Thau Lagoon and the Mediterranean sea, GREENSEA has a rare collection of species, full of beneficial molecules for the skin thanks to an affinity with no equivalence.

A CUSTOMISED SERVICE, WITH EXCLUSIVE OR PERSONALISED ACTIVE INGREDIENTS

GREENTECH develops specific, customised actives for the most demanding brands in the market either exclusively or using existing active ingredients that are adapted to their demands.

Reactivity and Flexibility are the master words in the company.

The GREENTECH’s factory produces in volumes of between 50 kg to 200 t.

A GROUP THAT IS THRIVING

Production site and international presence in constant development : more than 10 000 m2, including 2000 m2 of laboratories equipped with the most sophisticated active ingredients’extraction analysis, stabilisation.

A HIGHLY COMMITTED GROUP, BUILT ON SUSTAINABLE DEVELOPMENT AND FAIR TRADE

Confident that ethic is a source of progress, GREENTECH was also a pioneer in being the first to adopt sustainable practices and fair trade. It has forged long term partnerships based on equal and mutual benefits: Madagascar, Peru, Burkina Faso…

Fully committed to the preservation of rare or threatened species, Greentech collaborates with local communities in over 20 countries around the world from the North and South poles to the Equator.

AN INFINITE SOURCE OF INNOVATIVE ASSETS Harvested from the oceans and seas of the earth and in sometimes extreme environments, macroalgae and marine plants selected by GREENSEA present original cosmetic activities, as well as microalgae produced under controlled conditions. In addition to the extreme diversity of cultivated species, the innovative technique of metabolic orientation developed by GREENSEA makes it possible to create new assets that meet the different needs of the skin and hair.

BLUE BIOTECHNOLOGIES, A PRIVILEGED PATH TO SUSTAINABLE DEVELOPMENT

This unlimited biodiversity makes it possible to develop totally natural and high-tech assets, sources of beauty, with a sustainable development philosophy that is at the heart of GREENSEA and the GREENTECH GROUP.

ONE OF THE EUROPEAN LEADERS

The activity of GREENSEA is totally integrated, from the culture tube to the commercial ingredient. Its large collection of exotic and extremophilic microalgae and cyanobacteria, its expertise in physiological stress for oriented microalgae cultures, its industrial biological cultures in a controlled environment, as well as its 100m³ production capacity on 3 types of closed systems, its quality assurance and the reliability of its traceability make GREENSEA the reference for microalgae in France and one of the European leaders. A pioneer in botanical biotechnology at its creation in 1992, GREENTECH develops high technology extracts and active

ingredients derived from the internal mechanisms of plants, algae, micro-algae and microorganisms from around the world for cosmetics, pharmaceutics and nutraceutics.

A Group of companies dedicated to each biological universe:

BIOVITIS has more than 25 years experience in the production of microorganisms and transformation into innovative ingredients for several markets as Agronomy, Environment, Cosmetic, Pharmacy and Agroindus- try. BIOVITIS has a collection of more than 500 microbial strains in its catalog (bacteria, yeasts and fungi)

Active ingredients and extracts derived from micro-algae, algae and halophyte plants for nutraceutics, dietetics, cosmetics, immunodiagnostics and aquaculture.

MARINE Active ingredients and extracts

derived from plants and biotechnologies for nutraceutics,

pharmaceutics and cosmetics.

BOTANICAL

Biovitis

Microbial biotechnology for nutritional, agronomic, pharmaceutical, dermocosmetic

and environmental purposes.

MICROBIAL

Active ingredients derived from Brazilian biodiversity for the cosmetics, pharmaceutics and

nutraceutics markets.

BRAZILIAN BIODIVERSITY

A PIONEERING GROUP, BIOTECHNOLOGY EXPERT FROM ALL NATURAL ENVIRONMENTS

BIOVITIS

Actifs et extraits issus de végétaux et biotechnolgies, pour la nutraceutique,

pharmaceutique et cosmétique

Actifs et extraits issus des microalgues, algues et des plantes

marines côtières, destinés à la nutraceutique, diététique, cosmétique,

immunodiagnostic et aquaculture

Biotechnologies microbiennes d’intérêt alimentaires, agronomique,

pharmaceutique, dermocosmétique et environnemental

Actifs et extraits issus de la biodiversité brésilenne, pour la

nutraceutique, pharmaceutique et cosmétique

GREENTECH

AN UNLIMITED RESOURCE

GREENTECH gathers its resources from every continent in order to exploit the natural adaptive systems of regional species.

GREENTECH has uncovered over 300,000 bioactive molecules across the world’s latitudes and longitudes, developed a hundred active ingredients and over 3,000 extracts.

CUTTING EDGE RESEARCH

Researchers (one third of our staff) have for over 20 years shared their scientific knowledge across all disciplines (plant biology, botanical science, phytochemistry, microbiology, biochemistry, chemistry, algology, nutrition, cosmetics, etc.).

The laboratory possesses its own data bank of over 30,000 botanicals and 300,000 biological molecules.

High-tech processes used by the pharmaceutics industry transform natural ingredients into actives: ethnobotany, bio-informatics with molecular modelling, transcriptomic analysis (complete genome), fermentation, a patented cryoextraction system that preserves the plants’ active essence...

Mastery of high technologies witnessed by numerous quality accreditations and awards.

Every year, over 15% of turnover is reinvested in R&D.

MICROORGANISMS : AN INEXHAUSTIBLE SOURCE OF DIVERSITY TO MEET THE TOMORROW’S CHALLENGES

GREENSEA values the immense potential of marine and freshwater plants to create, by biotechnological means, totally innovative natural cosmetic active ingredients and extracts.

GREENSEA extracts, purifies, characterizes and transforms active molecules derived from algae and marine plants into highly effective ingredients; proven performance by transcriptomic predictive assays, in vitro cell assays, and in vivo volunteer assays.

Located in Mèze along the Thau Lagoon and the Mediterranean sea, GREENSEA has a rare collection of species, full of beneficial molecules for the skin thanks to an affinity with no equivalence.

A CUSTOMISED SERVICE, WITH EXCLUSIVE OR PERSONALISED ACTIVE INGREDIENTS

GREENTECH develops specific, customised actives for the most demanding brands in the market either exclusively or using existing active ingredients that are adapted to their demands.

Reactivity and Flexibility are the master words in the company.

The GREENTECH’s factory produces in volumes of between 50 kg to 200 t.

A GROUP THAT IS THRIVING

Production site and international presence in constant development : more than 10 000 m2, including 2000 m2 of laboratories equipped with the most sophisticated active ingredients’extraction analysis, stabilisation.

A HIGHLY COMMITTED GROUP, BUILT ON SUSTAINABLE DEVELOPMENT AND FAIR TRADE

Confident that ethic is a source of progress, GREENTECH was also a pioneer in being the first to adopt sustainable practices and fair trade. It has forged long term partnerships based on equal and mutual benefits: Madagascar, Peru, Burkina Faso…

Fully committed to the preservation of rare or threatened species, Greentech collaborates with local communities in over 20 countries around the world from the North and South poles to the Equator.

AN INFINITE SOURCE OF INNOVATIVE ASSETS Harvested from the oceans and seas of the earth and in sometimes extreme environments, macroalgae and marine plants selected by GREENSEA present original cosmetic activities, as well as microalgae produced under controlled conditions. In addition to the extreme diversity of cultivated species, the innovative technique of metabolic orientation developed by GREENSEA makes it possible to create new assets that meet the different needs of the skin and hair.

BLUE BIOTECHNOLOGIES, A PRIVILEGED PATH TO SUSTAINABLE DEVELOPMENT

This unlimited biodiversity makes it possible to develop totally natural and high-tech assets, sources of beauty, with a sustainable development philosophy that is at the heart of GREENSEA and the GREENTECH GROUP.

ONE OF THE EUROPEAN LEADERS

The activity of GREENSEA is totally integrated, from the culture tube to the commercial ingredient. Its large collection of exotic and extremophilic microalgae and cyanobacteria, its expertise in physiological stress for oriented microalgae cultures, its industrial biological cultures in a controlled environment, as well as its 100m³ production capacity on 3 types of closed systems, its quality assurance and the reliability of its traceability make GREENSEA the reference for microalgae in France and one of the European leaders.

A pioneer in botanical biotechnology at its creation in 1992, GREENTECH develops high technology extracts and active ingredients derived from the internal mechanisms of plants, algae, micro-algae and microorganisms from around the world for cosmetics, pharmaceutics and nutraceutics.

A Group of companies dedicated to each biological universe:

BIOVITIS has more than 25 years experience in the production of microorganisms and transformation into innovative ingredients for several markets as Agronomy, Environment, Cosmetic, Pharmacy and Agroindus- try. BIOVITIS has a collection of more than 500 microbial strains in its catalog (bacteria, yeasts and fungi)

Active ingredients and extracts derived from micro-algae, algae and halophyte plants for nutraceutics, dietetics, cosmetics, immunodiagnostics and aquaculture.

MARINE Active ingredients and extracts

derived from plants and biotechnologies for nutraceutics,

pharmaceutics and cosmetics.

BOTANICAL

Biovitis

Microbial biotechnology for nutritional, agronomic, pharmaceutical, dermocosmetic

and environmental purposes.

MICROBIAL

Active ingredients derived from Brazilian biodiversity for the cosmetics, pharmaceutics and

nutraceutics markets.

BRAZILIAN BIODIVERSITY

A PIONEERING GROUP, BIOTECHNOLOGY EXPERT FROM ALL NATURAL ENVIRONMENTS

BIOVITIS

UNE SOURCE ILLIMITÉE D’ACTIFS

GREENTECH

AN UNLIMITED RESOURCE

GREENTECH gathers its resources from every continent in order to exploit the natural adaptive systems of regional species.

GREENTECH has uncovered over 300,000 bioactive molecules across the world’s latitudes and longitudes, developed a hundred active ingredients and over 3,000 extracts.

CUTTING EDGE RESEARCH

Researchers (one third of our staff) have for over 20 years shared their scientific knowledge across all disciplines (plant biology, botanical science, phytochemistry, microbiology, biochemistry, chemistry, algology, nutrition, cosmetics, etc.).

The laboratory possesses its own data bank of over 30,000 botanicals and 300,000 biological molecules.

High-tech processes used by the pharmaceutics industry transform natural ingredients into actives: ethnobotany, bio-informatics with molecular modelling, transcriptomic analysis (complete genome), fermentation, a patented cryoextraction system that preserves the plants’ active essence...

Mastery of high technologies witnessed by numerous quality accreditations and awards.

Every year, over 15% of turnover is reinvested in R&D.

MICROORGANISMS : AN INEXHAUSTIBLE SOURCE OF DIVERSITY TO MEET THE TOMORROW’S CHALLENGES

GREENSEA values the immense potential of marine and freshwater plants to create, by biotechnological means, totally innovative natural cosmetic active ingredients and extracts.

GREENSEA extracts, purifies, characterizes and transforms active molecules derived from algae and marine plants into highly effective ingredients; proven performance by transcriptomic predictive assays, in vitro cell assays, and in vivo volunteer assays.

Located in Mèze along the Thau Lagoon and the Mediterranean sea, GREENSEA has a rare collection of species, full of beneficial molecules for the skin thanks to an affinity with no equivalence.

A CUSTOMISED SERVICE, WITH EXCLUSIVE OR PERSONALISED ACTIVE INGREDIENTS

GREENTECH develops specific, customised actives for the most demanding brands in the market either exclusively or using existing active ingredients that are adapted to their demands.

Reactivity and Flexibility are the master words in the company.

The GREENTECH’s factory produces in volumes of between 50 kg to 200 t.

A GROUP THAT IS THRIVING

Production site and international presence in constant development : more than 10 000 m2, including 2000 m2 of laboratories equipped with the most sophisticated active ingredients’extraction analysis, stabilisation.

A HIGHLY COMMITTED GROUP, BUILT ON SUSTAINABLE DEVELOPMENT AND FAIR TRADE

Confident that ethic is a source of progress, GREENTECH was also a pioneer in being the first to adopt sustainable practices and fair trade. It has forged long term partnerships based on equal and mutual benefits: Madagascar, Peru, Burkina Faso…

Fully committed to the preservation of rare or threatened species, Greentech collaborates with local communities in over 20 countries around the world from the North and South poles to the Equator.

AN INFINITE SOURCE OF INNOVATIVE ASSETS Harvested from the oceans and seas of the earth and in sometimes extreme environments, macroalgae and marine plants selected by GREENSEA present original cosmetic activities, as well as microalgae produced under controlled conditions. In addition to the extreme diversity of cultivated species, the innovative technique of metabolic orientation developed by GREENSEA makes it possible to create new assets that meet the different needs of the skin and hair.

BLUE BIOTECHNOLOGIES, A PRIVILEGED PATH TO SUSTAINABLE DEVELOPMENT

This unlimited biodiversity makes it possible to develop totally natural and high-tech assets, sources of beauty, with a sustainable development philosophy that is at the heart of GREENSEA and the GREENTECH GROUP.

ONE OF THE EUROPEAN LEADERS

The activity of GREENSEA is totally integrated, from the culture tube to the commercial ingredient. Its large collection of exotic and extremophilic microalgae and cyanobacteria, its expertise in physiological stress for oriented microalgae cultures, its industrial biological cultures in a controlled environment, as well as its 100m³ production capacity on 3 types of closed systems, its quality assurance and the reliability of its traceability make GREENSEA the reference for microalgae in France and one of the European leaders.

A pioneer in botanical biotechnology at its creation in 1992, GREENTECH develops high technology extracts and active ingredients derived from the internal mechanisms of plants, algae, micro-algae and microorganisms from around the world for cosmetics, pharmaceutics and nutraceutics.

A Group of companies dedicated to each biological universe:

BIOVITIS has more than 25 years experience in the production of microorganisms and transformation into innovative ingredients for several markets as Agronomy, Environment, Cosmetic, Pharmacy and Agroindus- try. BIOVITIS has a collection of more than 500 microbial strains in its catalog (bacteria, yeasts and fungi)

Active ingredients and extracts derived from micro-algae, algae and halophyte plants for nutraceutics, dietetics, cosmetics, immunodiagnostics and aquaculture.

MARINE Active ingredients and extracts

derived from plants and biotechnologies for nutraceutics,

pharmaceutics and cosmetics.

BOTANICAL

Biovitis

Microbial biotechnology for nutritional, agronomic, pharmaceutical, dermocosmetic

and environmental purposes.

MICROBIAL

Active ingredients derived from Brazilian biodiversity for the cosmetics, pharmaceutics and

nutraceutics markets.

BRAZILIAN BIODIVERSITY

A PIONEERING GROUP, BIOTECHNOLOGY EXPERT FROM ALL NATURAL ENVIRONMENTS

BIOVITIS

UNE OFFRE SUR MESURE, AVEC DES ACTIFS EXCLUSIFS OU PERSONNALISÉS

GREENTECH

AN UNLIMITED RESOURCE

GREENTECH gathers its resources from every continent in order to exploit the natural adaptive systems of regional species.

GREENTECH has uncovered over 300,000 bioactive molecules across the world’s latitudes and longitudes, developed a hundred active ingredients and over 3,000 extracts.

CUTTING EDGE RESEARCH

Researchers (one third of our staff) have for over 20 years shared their scientific knowledge across all disciplines (plant biology, botanical science, phytochemistry, microbiology, biochemistry, chemistry, algology, nutrition, cosmetics, etc.).

The laboratory possesses its own data bank of over 30,000 botanicals and 300,000 biological molecules.

High-tech processes used by the pharmaceutics industry transform natural ingredients into actives: ethnobotany, bio-informatics with molecular modelling, transcriptomic analysis (complete genome), fermentation, a patented cryoextraction system that preserves the plants’ active essence...

Mastery of high technologies witnessed by numerous quality accreditations and awards.

Every year, over 15% of turnover is reinvested in R&D.

MICROORGANISMS : AN INEXHAUSTIBLE SOURCE OF DIVERSITY TO MEET THE TOMORROW’S CHALLENGES

GREENSEA values the immense potential of marine and freshwater plants to create, by biotechnological means, totally innovative natural cosmetic active ingredients and extracts.

GREENSEA extracts, purifies, characterizes and transforms active molecules derived from algae and marine plants into highly effective ingredients; proven performance by transcriptomic predictive assays, in vitro cell assays, and in vivo volunteer assays.

Located in Mèze along the Thau Lagoon and the Mediterranean sea, GREENSEA has a rare collection of species, full of beneficial molecules for the skin thanks to an affinity with no equivalence.

A CUSTOMISED SERVICE, WITH EXCLUSIVE OR PERSONALISED ACTIVE INGREDIENTS

GREENTECH develops specific, customised actives for the most demanding brands in the market either exclusively or using existing active ingredients that are adapted to their demands.

Reactivity and Flexibility are the master words in the company.

The GREENTECH’s factory produces in volumes of between 50 kg to 200 t.

A GROUP THAT IS THRIVING

Production site and international presence in constant development : more than 10 000 m2, including 2000 m2 of laboratories equipped with the most sophisticated active ingredients’extraction analysis, stabilisation.

A HIGHLY COMMITTED GROUP, BUILT ON SUSTAINABLE DEVELOPMENT AND FAIR TRADE

Confident that ethic is a source of progress, GREENTECH was also a pioneer in being the first to adopt sustainable practices and fair trade. It has forged long term partnerships based on equal and mutual benefits: Madagascar, Peru, Burkina Faso…

Fully committed to the preservation of rare or threatened species, Greentech collaborates with local communities in over 20 countries around the world from the North and South poles to the Equator.

AN INFINITE SOURCE OF INNOVATIVE ASSETS Harvested from the oceans and seas of the earth and in sometimes extreme environments, macroalgae and marine plants selected by GREENSEA present original cosmetic activities, as well as microalgae produced under controlled conditions. In addition to the extreme diversity of cultivated species, the innovative technique of metabolic orientation developed by GREENSEA makes it possible to create new assets that meet the different needs of the skin and hair.

BLUE BIOTECHNOLOGIES, A PRIVILEGED PATH TO SUSTAINABLE DEVELOPMENT

This unlimited biodiversity makes it possible to develop totally natural and high-tech assets, sources of beauty, with a sustainable development philosophy that is at the heart of GREENSEA and the GREENTECH GROUP.

ONE OF THE EUROPEAN LEADERS

The activity of GREENSEA is totally integrated, from the culture tube to the commercial ingredient. Its large collection of exotic and extremophilic microalgae and cyanobacteria, its expertise in physiological stress for oriented microalgae cultures, its industrial biological cultures in a controlled environment, as well as its 100m³ production capacity on 3 types of closed systems, its quality assurance and the reliability of its traceability make GREENSEA the reference for microalgae in France and one of the European leaders.

A pioneer in botanical biotechnology at its creation in 1992, GREENTECH develops high technology extracts and active ingredients derived from the internal mechanisms of plants, algae, micro-algae and microorganisms from around the world for cosmetics, pharmaceutics and nutraceutics.

A Group of companies dedicated to each biological universe:

BIOVITIS has more than 25 years experience in the production of microorganisms and transformation into innovative ingredients for several markets as Agronomy, Environment, Cosmetic, Pharmacy and Agroindus- try. BIOVITIS has a collection of more than 500 microbial strains in its catalog (bacteria, yeasts and fungi)

Active ingredients and extracts derived from micro-algae, algae and halophyte plants for nutraceutics, dietetics, cosmetics, immunodiagnostics and aquaculture.

MARINE Active ingredients and extracts

derived from plants and biotechnologies for nutraceutics,

pharmaceutics and cosmetics.

BOTANICAL

Biovitis

Microbial biotechnology for nutritional, agronomic, pharmaceutical, dermocosmetic

and environmental purposes.

MICROBIAL

Active ingredients derived from Brazilian biodiversity for the cosmetics, pharmaceutics and

nutraceutics markets.

BRAZILIAN BIODIVERSITY

A PIONEERING GROUP, BIOTECHNOLOGY EXPERT FROM ALL NATURAL ENVIRONMENTS

BIOVITIS

UN GROUPE EN PLEIN ESSOR

GREENTECH

AN UNLIMITED RESOURCE

GREENTECH gathers its resources from every continent in order to exploit the natural adaptive systems of regional species.

GREENTECH has uncovered over 300,000 bioactive molecules across the world’s latitudes and longitudes, developed a hundred active ingredients and over 3,000 extracts.

CUTTING EDGE RESEARCH

Researchers (one third of our staff) have for over 20 years shared their scientific knowledge across all disciplines (plant biology, botanical science, phytochemistry, microbiology, biochemistry, chemistry, algology, nutrition, cosmetics, etc.).

The laboratory possesses its own data bank of over 30,000 botanicals and 300,000 biological molecules.

High-tech processes used by the pharmaceutics industry transform natural ingredients into actives: ethnobotany, bio-informatics with molecular modelling, transcriptomic analysis (complete genome), fermentation, a patented cryoextraction system that preserves the plants’ active essence...

Mastery of high technologies witnessed by numerous quality accreditations and awards.

Every year, over 15% of turnover is reinvested in R&D.

MICROORGANISMS : AN INEXHAUSTIBLE SOURCE OF DIVERSITY TO MEET THE TOMORROW’S CHALLENGES

GREENSEA values the immense potential of marine and freshwater plants to create, by biotechnological means, totally innovative natural cosmetic active ingredients and extracts.

GREENSEA extracts, purifies, characterizes and transforms active molecules derived from algae and marine plants into highly effective ingredients; proven performance by transcriptomic predictive assays, in vitro cell assays, and in vivo volunteer assays.

Located in Mèze along the Thau Lagoon and the Mediterranean sea, GREENSEA has a rare collection of species, full of beneficial molecules for the skin thanks to an affinity with no equivalence.

A CUSTOMISED SERVICE, WITH EXCLUSIVE OR PERSONALISED ACTIVE INGREDIENTS

GREENTECH develops specific, customised actives for the most demanding brands in the market either exclusively or using existing active ingredients that are adapted to their demands.

Reactivity and Flexibility are the master words in the company.

The GREENTECH’s factory produces in volumes of between 50 kg to 200 t.

A GROUP THAT IS THRIVING

Production site and international presence in constant development : more than 10 000 m2, including 2000 m2 of laboratories equipped with the most sophisticated active ingredients’extraction analysis, stabilisation.

A HIGHLY COMMITTED GROUP, BUILT ON SUSTAINABLE DEVELOPMENT AND FAIR TRADE

Confident that ethic is a source of progress, GREENTECH was also a pioneer in being the first to adopt sustainable practices and fair trade. It has forged long term partnerships based on equal and mutual benefits: Madagascar, Peru, Burkina Faso…

Fully committed to the preservation of rare or threatened species, Greentech collaborates with local communities in over 20 countries around the world from the North and South poles to the Equator.

AN INFINITE SOURCE OF INNOVATIVE ASSETS Harvested from the oceans and seas of the earth and in sometimes extreme environments, macroalgae and marine plants selected by GREENSEA present original cosmetic activities, as well as microalgae produced under controlled conditions. In addition to the extreme diversity of cultivated species, the innovative technique of metabolic orientation developed by GREENSEA makes it possible to create new assets that meet the different needs of the skin and hair.

BLUE BIOTECHNOLOGIES, A PRIVILEGED PATH TO SUSTAINABLE DEVELOPMENT

This unlimited biodiversity makes it possible to develop totally natural and high-tech assets, sources of beauty, with a sustainable development philosophy that is at the heart of GREENSEA and the GREENTECH GROUP.

ONE OF THE EUROPEAN LEADERS

The activity of GREENSEA is totally integrated, from the culture tube to the commercial ingredient. Its large collection of exotic and extremophilic microalgae and cyanobacteria, its expertise in physiological stress for oriented microalgae cultures, its industrial biological cultures in a controlled environment, as well as its 100m³ production capacity on 3 types of closed systems, its quality assurance and the reliability of its traceability make GREENSEA the reference for microalgae in France and one of the European leaders.

A pioneer in botanical biotechnology at its creation in 1992, GREENTECH develops high technology extracts and active ingredients derived from the internal mechanisms of plants, algae, micro-algae and microorganisms from around the world for cosmetics, pharmaceutics and nutraceutics.

A Group of companies dedicated to each biological universe:

BIOVITIS has more than 25 years experience in the production of microorganisms and transformation into innovative ingredients for several markets as Agronomy, Environment, Cosmetic, Pharmacy and Agroindus- try. BIOVITIS has a collection of more than 500 microbial strains in its catalog (bacteria, yeasts and fungi)

Active ingredients and extracts derived from micro-algae, algae and halophyte plants for nutraceutics, dietetics, cosmetics, immunodiagnostics and aquaculture.

MARINE Active ingredients and extracts

derived from plants and biotechnologies for nutraceutics,

pharmaceutics and cosmetics.

BOTANICAL

Biovitis

Microbial biotechnology for nutritional, agronomic, pharmaceutical, dermocosmetic

and environmental purposes.

MICROBIAL

Active ingredients derived from Brazilian biodiversity for the cosmetics, pharmaceutics and

nutraceutics markets.

BRAZILIAN BIODIVERSITY

A PIONEERING GROUP, BIOTECHNOLOGY EXPERT FROM ALL NATURAL ENVIRONMENTS

BIOVITIS

UN GROUPE ENGAGÉ, CONSTRUIT SELON UN DÉVELOPPEMENT DURABLE ET UN COMMERCE ÉQUITABLE

GREENTECH

AN UNLIMITED RESOURCE

GREENTECH gathers its resources from every continent in order to exploit the natural adaptive systems of regional species.

GREENTECH has uncovered over 300,000 bioactive molecules across the world’s latitudes and longitudes, developed a hundred active ingredients and over 3,000 extracts.

CUTTING EDGE RESEARCH

Researchers (one third of our staff) have for over 20 years shared their scientific knowledge across all disciplines (plant biology, botanical science, phytochemistry, microbiology, biochemistry, chemistry, algology, nutrition, cosmetics, etc.).

The laboratory possesses its own data bank of over 30,000 botanicals and 300,000 biological molecules.

High-tech processes used by the pharmaceutics industry transform natural ingredients into actives: ethnobotany, bio-informatics with molecular modelling, transcriptomic analysis (complete genome), fermentation, a patented cryoextraction system that preserves the plants’ active essence...

Mastery of high technologies witnessed by numerous quality accreditations and awards.

Every year, over 15% of turnover is reinvested in R&D.

MICROORGANISMS : AN INEXHAUSTIBLE SOURCE OF DIVERSITY TO MEET THE TOMORROW’S CHALLENGES

GREENSEA values the immense potential of marine and freshwater plants to create, by biotechnological means, totally innovative natural cosmetic active ingredients and extracts.

GREENSEA extracts, purifies, characterizes and transforms active molecules derived from algae and marine plants into highly effective ingredients; proven performance by transcriptomic predictive assays, in vitro cell assays, and in vivo volunteer assays.

Located in Mèze along the Thau Lagoon and the Mediterranean sea, GREENSEA has a rare collection of species, full of beneficial molecules for the skin thanks to an affinity with no equivalence.

A CUSTOMISED SERVICE, WITH EXCLUSIVE OR PERSONALISED ACTIVE INGREDIENTS

GREENTECH develops specific, customised actives for the most demanding brands in the market either exclusively or using existing active ingredients that are adapted to their demands.

Reactivity and Flexibility are the master words in the company.

The GREENTECH’s factory produces in volumes of between 50 kg to 200 t.

A GROUP THAT IS THRIVING

Production site and international presence in constant development : more than 10 000 m2, including 2000 m2 of laboratories equipped with the most sophisticated active ingredients’extraction analysis, stabilisation.

A HIGHLY COMMITTED GROUP, BUILT ON SUSTAINABLE DEVELOPMENT AND FAIR TRADE

Confident that ethic is a source of progress, GREENTECH was also a pioneer in being the first to adopt sustainable practices and fair trade. It has forged long term partnerships based on equal and mutual benefits: Madagascar, Peru, Burkina Faso…

Fully committed to the preservation of rare or threatened species, Greentech collaborates with local communities in over 20 countries around the world from the North and South poles to the Equator.

AN INFINITE SOURCE OF INNOVATIVE ASSETS Harvested from the oceans and seas of the earth and in sometimes extreme environments, macroalgae and marine plants selected by GREENSEA present original cosmetic activities, as well as microalgae produced under controlled conditions. In addition to the extreme diversity of cultivated species, the innovative technique of metabolic orientation developed by GREENSEA makes it possible to create new assets that meet the different needs of the skin and hair.

BLUE BIOTECHNOLOGIES, A PRIVILEGED PATH TO SUSTAINABLE DEVELOPMENT

This unlimited biodiversity makes it possible to develop totally natural and high-tech assets, sources of beauty, with a sustainable development philosophy that is at the heart of GREENSEA and the GREENTECH GROUP.

ONE OF THE EUROPEAN LEADERS

The activity of GREENSEA is totally integrated, from the culture tube to the commercial ingredient. Its large collection of exotic and extremophilic microalgae and cyanobacteria, its expertise in physiological stress for oriented microalgae cultures, its industrial biological cultures in a controlled environment, as well as its 100m³ production capacity on 3 types of closed systems, its quality assurance and the reliability of its traceability make GREENSEA the reference for microalgae in France and one of the European leaders.

A pioneer in botanical biotechnology at its creation in 1992, GREENTECH develops high technology extracts and active ingredients derived from the internal mechanisms of plants, algae, micro-algae and microorganisms from around the world for cosmetics, pharmaceutics and nutraceutics.

A Group of companies dedicated to each biological universe:

BIOVITIS has more than 25 years experience in the production of microorganisms and transformation into innovative ingredients for several markets as Agronomy, Environment, Cosmetic, Pharmacy and Agroindus- try. BIOVITIS has a collection of more than 500 microbial strains in its catalog (bacteria, yeasts and fungi)

Active ingredients and extracts derived from micro-algae, algae and halophyte plants for nutraceutics, dietetics, cosmetics, immunodiagnostics and aquaculture.

MARINE Active ingredients and extracts

derived from plants and biotechnologies for nutraceutics,

pharmaceutics and cosmetics.

BOTANICAL

Biovitis

Microbial biotechnology for nutritional, agronomic, pharmaceutical, dermocosmetic

and environmental purposes.

MICROBIAL

Active ingredients derived from Brazilian biodiversity for the cosmetics, pharmaceutics and

nutraceutics markets.

BRAZILIAN BIODIVERSITY

A PIONEERING GROUP, BIOTECHNOLOGY EXPERT FROM ALL NATURAL ENVIRONMENTS

BIOVITIS

UNE RECHERCHE DE POINTE

GREENTECH puise ses ressources sur tous les continents afin d’exploiter les systèmes adaptatifs naturels des espèces locales.

GREENTECH a déniché plus de 30 000 molécules bio-actives, déve- loppé une centaine d’actifs et plus de 3 000 extraits

Des chercheurs (un tiers du personnel) unissent depuis plus de 25 ans leurs expertises scientifiques dans toutes les disciplines (bio- logie végétale, phytochimie, microbiologie, biochimie, chimie, algo- logie, nutrition, cosmétique...)

Le laboratoire possède sa propre banque de données, avec plus de 30 000 plantes et 300 000 molécules biologiques.

Des process hight-tech, utilisés par la pharmacie, transforment les ingrédients naturels en actifs : ethnobotanique, bio-informatique avec modélisation moléculaire, étude transcriptomique (génome complet), fermentation, système breveté de cryo-extraction qui préserve la quintessence de l’activité végétale...

Une maitrise des hautes technologies récompensée par les nom- breuses certifications de qualité obtenues, ainsi que plusieurs prix.

Plus de 15% du CA est réinvesti tous les ans en R&D.

GREENTECH élabore sur mesure pour les marques les plus exi- geantes des actifs spécifiques en toute exclusivité ou adapte se- lon leurs demandes des actifs existants. Hyper réactifs et flexibles, nous produisons par lots de 50 kg à 200 tonnes.

Un site de production et une présence internationales en constant développement : plus de 10 000 m2 , dont 2 000 pour les labora- toires équipés des technologies les plus sophistiquées pour ex- traire, analyser et stabiliser les actifs.

Convaincue que l’éthique est source de progrès, GREENTECH a ici encore été pionnier dès sa création, en adoptant la première une démarche de développement durable et de commerce équitable.

Elle a tissé des partenariats de long terme, de l’Auvergne jusqu’au Pérou ou au Burkina Faso, avec des relations égalitaires et des bé- néfices réciproques.

Fortement impliquée dans la préservation des espèces rares ou menacées, elle collabore avec des communautés locales dans plus de 20 pays, à travers le monde, des pôles à l’équateur.

Références

Documents relatifs

The experiment of solving the problem of expert classification suggests that the assumption of ordering the meaning of the attribute is also valid for many

Pioneering work was don e on rule- based systems, and was desig ned to deal with medical applications, but their greatest successes have occurred in fields other

6 expert control model derived from a case study related to the Control Risk Resiliency project, based on detailed research methods, and with results showing

This plan is the result of a negotiation between the Berlin Senate and the housing company as part of another federal program, Stadtumbau Ost (City Reconstruction in East

[r]

L3

The new knowledge necessary for the early stage of innovation process in biotech- nology can be generated by two alternative means: On the one hand, an organization’s own R&D

This paper introduces a tool, namely ACRES (Automatic CReator of Expert Systems), which can automatically produce rule- based expert systems as CLIPS scripts from